Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
07/2010
07/20/2010CA2407866C Process for the synthesis of amine ethers from secondary amino oxides
07/20/2010CA2399001C Integrin expression inhibitor
07/15/2010WO2010080481A1 Carbazole carboxamide compounds useful as kinase inhibitors
07/15/2010WO2010080474A1 Carbazole and carboline kinase inhibitors
07/15/2010WO2010079675A1 Method for manufacturing bicyclic aromatic hydroxycarboxylic acid
07/15/2010WO2010001167A3 Preparation of 3-pyrrole substituted 2-indolinone derivatives
07/15/2010US20100179332 Process for the purification of ropinirole hydrochloride
07/15/2010US20100179326 Benzamide derivative
07/15/2010US20100179325 Compound having 11beta-hsd1 inhibitory activity
07/15/2010US20100179207 Compounds
07/15/2010US20100179145 Pharmaceutical combinations
07/15/2010US20100179122 Non-Nucleoside Reverse Transcriptase Inhibitors
07/15/2010CA2747670A1 Carbazole carboxamide compounds useful as kinase inhibitors
07/14/2010EP2206716A1 Host material for light-emitting diodes
07/14/2010EP2206698A1 Ethynylindole compounds
07/14/2010EP2205560A1 Azabicyclo ý3. 1. 0¨hexyl derivatives as modulators of dopamine d3 receptors
07/14/2010EP2205559A1 Renin inhibitors
07/14/2010EP1652892B1 Cyanine compounds, optical recording materials and optical recording media
07/14/2010EP1648443B1 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands
07/14/2010EP1539141B1 3-(sulfonamidoethyl)-indole derivatives for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases
07/14/2010CN1914170B Synthetic methodology for the reductive alkylation at the c-3 position of indoles
07/14/2010CN101778906A Indolium compound and optical recording material using the compound
07/14/2010CN101778819A Indole indane amide compounds useful as cb2 agonists and method
07/14/2010CN101775357A Plant pathogenic fungi fusarium moniliforme natural antagonist
07/14/2010CN101775010A Carbazole-terminated heterofluorene main body material and preparation and application method
07/14/2010CN101775007A Tricyclene compounds with HIV antagonistic activity and preparation method and application thereof
07/14/2010CN101774962A Preparation method of compound 2-(1,3-dicarbonyl Isoindoline-2-yl)-3-substituted propane-2-olefine acid
07/14/2010CN101774961A Compound having affinity with progeria dementia A beta plaques, preparation method and application thereof
07/14/2010CN101774960A Preparation method of (2S)-indoline-2-methanoic acid
07/14/2010CN101774959A Preparation method and application of bromine-containing indole alkaloid
07/14/2010CN101774879A Method for simultaneously extracting high-purity beta-methylnaphthalene and indole from coal tar
07/14/2010CN101245047B Purification method for tryptophane
07/13/2010USRE41439 Pharmaceutical compositions and methods for use
07/13/2010US7754896 Indol-alanine derivatives as selective S1P4-agonists
07/13/2010US7754895 Process for the synthesis of progesterone receptor modulators
07/13/2010US7754894 Crystalline sulfonamide-containing indole compound and process for preparing the same
07/13/2010US7754893 Conjugates of biological substances
07/13/2010US7754886 N-acylsulfonamide apoptosis promoters
07/13/2010US7754772 (2R)-2,3-bis(nitrooxy)propyl(2S)-2(6-methoxy(2-naphthyl)propanoate, used for treating inflammation, pain and fever; gastrointestinal disorders; wound healing agents; preventing gastrointestinal, renal and/or respiratory toxicities; side effect reduction
07/13/2010US7754771 Compounds for the treatment of AIDS and other viral diseases
07/13/2010US7754756 N-(1-{3-[(R)-2-[3-(phenylsulphonylamino)-phenyl]-2-hydroxy-ethylamino]-3-methyl-butyl}-1H-indol-5-yl)-2-cyano-acetamide, used for treating non-insulin dependent diabetes, obesity or overactive bladder
07/13/2010US7754755 Inhibitors of 15-lipoxygenase
07/13/2010US7754740 ethyl 1-benzyl-5-(3-carboxypropoxy)-2-methyl-6-pyrid-3-yl-1H-indole-3-carboxylate; peroxisome proliferator activated receptors agonist; dyslipidaemia, atherosclerosis, diabetes, obesity; high level lipoprotein controllong
07/13/2010US7754735 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
07/13/2010US7754725 (2,4-Dihydroxy-5-isopropyl-phenyl)-[5-(2-dimethylamino-ethoxy)-1,3-dihydro-isoindol-2-yl]-methanone; inhibits or modulates activity of heat shock protein Hsp90; useful for treating cancer, particularly hematopoietic tumors of lymphoid or myeloid lineage, prostate, lung, breast cancer, melanoma
07/13/2010US7754654 Substituted spirocyclic ketoenols
07/13/2010CA2446463C Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
07/13/2010CA2352066C Process for the preparation of derivatized polymers
07/08/2010WO2010077839A1 Substituted oxindol cb2 agonists for pain treatment
07/08/2010WO2010077686A1 Isoindolinone and related analogs as sirtuin modulators
07/08/2010WO2010076566A2 Indoles useful in the treatment of inflammation
07/08/2010WO2009147031A3 Oxime ester photoinitiators
07/08/2010US20100174095 Organic compound, semiconductor film electrode employing the organic compound, photoelectric conversion element employing the organic compound, and photoelectrochemical solar cell employing the organic compound
07/08/2010US20100174090 Methods of preparing primary, secondary and tertiary carbinamine compounds in the presence of ammonia
07/08/2010US20100174084 2-Alkoxy-6-alkyl-phenyl-substituted Spirocyclic Tetramic Acid Derivatives
07/08/2010US20100174077 Processes and intermediates
07/08/2010US20100174075 Use of nitric oxide-releasing statins in the treatment of pulmonary arterial hypertension
07/08/2010US20100173993 Controlled release biocidal salts
07/08/2010US20100173968 Sub-type selective azabicycloalkane derivatives
07/08/2010US20100173851 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
07/08/2010US20100173849 Neo-tryptophan
07/08/2010US20100173778 3-Biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
07/08/2010US20100170418 Complexes of carbon nanotubes and fullerenes with molecular-clips and use thereof
07/08/2010CA2747602A1 3.1.0 bicyclic glyt1 inhibitors and methods of making and using same
07/08/2010CA2746221A1 Isoindolinone and related analogs as sirtuin modulators
07/07/2010EP2203424A1 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity
07/07/2010EP2203423A1 Indoline compounds
07/07/2010CN101768118A Bi-imidazoline diphenylamine compound and preparation method thereof
07/07/2010CN101768090A Organic light-emitting material 4,4 '-bis-arylation acetenyl azobenzol compound, synthesis method and application
07/06/2010US7750163 Cyanine dye labelling reagents
07/06/2010US7750042 substituted bis[thio-hydrazide amide] compounds; synergistic effect with taxol or taxotere, anticancer agents, minimal toxic side-effects
07/06/2010US7750038 1-methyl-5-[1-(methylsulfonyl)-2,3-dihydro-1H-indol-5-yl]-1H-pyrrole-2-carbonitrile; contraception; fibroids, uterine leiomyomata, endometriosis, dysfunctional bleeding, polycystic ovary syndrome, and hormone-dependent carcinomas; providing hormone replacement therapy; stimulating food intake
07/06/2010US7750036 Carvedilol salts, corresponding compositions, methods of delivery and/or treatment
07/06/2010US7750021 3-{[2-(2-Trifluoromethyl-biphenyl-4-yl)-benzo[b]thiophen-5-ylmethyl]-amino}-propionic acid, useful in the treatment or prevention diseases associated with endothelial differentiation, G-protein-coupled (EDG) receptor mediated signal transduction, such as acute or chronic transplant rejection
07/06/2010CA2437109C Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
07/01/2010WO2010075064A1 Triple reuptake inhibitors and methods of their use
07/01/2010WO2010074779A1 Oxidation of alkylaromatic compounds
07/01/2010WO2010074520A2 Novel organic semiconductor compound, method for preparing same, and organic semiconductor composition, and organic semiconductor thin film and element containing same
07/01/2010WO2010074326A1 Probe for a biological specimen and labelling method and screening method using the probe
07/01/2010WO2010073857A1 Near-infrared-ray absorbing material containing cyanine compound, and cyanine compound
07/01/2010WO2010073719A1 Eg5 inhibitor
07/01/2010WO2010073253A1 Method for preparing an optically active frovatriptan
07/01/2010WO2010072144A1 Substituted phenylpiperazinyl aralkylalcohol derivatives, pharmaceutical compositions containing such derivatives and uses thereof
07/01/2010WO2010021693A3 Mif modulators
07/01/2010US20100168441 Process for production of substituted benzene
07/01/2010US20100168440 Homogeneous Asymmetric Hydrogenation Process
07/01/2010US20100168429 Transition metal catalyzed synthesis of N-aminoindoles
07/01/2010US20100168413 One-pot synthesis of benzisoindolenines used in the preparation of naphthalocyanines
07/01/2010US20100168101 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
07/01/2010US20100168096 Acylguanidine derivative or salt thereof
07/01/2010US20100167995 Peptoid compounds
07/01/2010US20100167994 Targeting of ews-fli1 as anti-tumor therapy
07/01/2010US20100167927 Substituted Amino-Thiourea Compounds For Combating Animal Pests
07/01/2010US20100167333 Heavy Metal Binding Compounds and Their Method of Use
07/01/2010US20100166881 Novel IDO Inhibitors and Methods of Use Thereof
07/01/2010US20100163852 Material for light-emitting device and light-emitting device
07/01/2010CA2772760A1 Small molecule inhibitors of necroptosis
07/01/2010CA2747784A1 Pharmaceutical compounds
07/01/2010CA2746055A1 Triple reuptake inhibitors and methods of their use
06/2010
06/30/2010EP2202231A1 2,3-dihydroiminoisoindole derivative
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 458